GENinCode Plc (LON:GENI – Get Free Report) shares dropped 9.5% during mid-day trading on Thursday . The company traded as low as GBX 4.75 ($0.06) and last traded at GBX 4.75 ($0.06). Approximately 104,045 shares changed hands during trading, a decline of 52% from the average daily volume of 214,597 shares. The stock had previously closed at GBX 5.25 ($0.07).
GENinCode Stock Performance
The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.27. The firm has a 50 day moving average price of GBX 6.29 and a 200 day moving average price of GBX 6.95. The stock has a market cap of £8.41 million, a PE ratio of -95.00 and a beta of 0.66.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Further Reading
- Five stocks we like better than GENinCode
- Retail Stocks Investing, Explained
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- How to Invest in the FAANG Stocks
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Technology Stocks Explained: Here’s What to Know About Tech
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
